Vertex Pharmaceuticals Inc (VRTX)
Market Closed
13 Nov, 20:00
$
434. 52
+0.33
+0.08%
$
111.42B Market Cap
30.83 P/E Ratio
0% Div Yield
1,460,654 Volume
14.94 Eps
$ 434.19
Previous Close Day Range
430.85 441.17
Year Range
362.5 519.68
Want to track VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 82 days
| VRTX Vertex Pharmaceuticals Inc 9 Feb 2026 (In 2 months) | | 4.95 Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 4 Feb 2026 (In 2 months) | | 4.87 Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 10 Nov 2025 | | 4.61 Cons. EPS | 4.8 EPS |
| VRTX Vertex Pharmaceuticals Inc 3 Nov 2025 | | 4.55 Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Oct 2025 | | 4.63 Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 30 Jul 2025 | | 4.28 Cons. EPS | 4.52 EPS |
| VRTX Vertex Pharmaceuticals Inc 5 May 2025 | | 4.29 Cons. EPS | 4.06 EPS |
| VRTX Vertex Pharmaceuticals Inc 3 Feb 2025 | | 4.02 Cons. EPS | 3.98 EPS |
| VRTX Vertex Pharmaceuticals Inc 4 Nov 2024 | | 4.14 Cons. EPS | 4.38 EPS |
| VRTX Vertex Pharmaceuticals Inc 30 Jul 2024 | | 4.17 Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 4 Jun 2024 | | 4.06 Cons. EPS | 4.76 EPS |
| VRTX Vertex Pharmaceuticals Inc 6 May 2024 | | 4.06 Cons. EPS | 4.76 EPS |
| VRTX Vertex Pharmaceuticals Inc 5 Feb 2024 | | 4.1 Cons. EPS | 4.2 EPS |
| VRTX Vertex Pharmaceuticals Inc 6 Nov 2023 | | 3.97 Cons. EPS | 4.08 EPS |
| VRTX Vertex Pharmaceuticals Inc 25 Oct 2016 | | 0.18 Cons. EPS | 0.16 EPS |
| VRTX Vertex Pharmaceuticals Inc 27 Jul 2016 | | 0.21 Cons. EPS | 0.24 EPS |
| VRTX Vertex Pharmaceuticals Inc 27 Apr 2016 | | 0.29 Cons. EPS | 0.09 EPS |
| VRTX Vertex Pharmaceuticals Inc 27 Jan 2016 | | 0.17 Cons. EPS | 0.17 EPS |
| VRTX Vertex Pharmaceuticals Inc 28 Oct 2015 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Jul 2015 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Apr 2015 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 28 Jan 2015 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 28 Oct 2014 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Jul 2014 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 1 May 2014 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Jan 2014 | | - Cons. EPS | 0.19 EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Oct 2013 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Jul 2013 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 30 Apr 2013 | | - Cons. EPS | - EPS |
| VRTX Vertex Pharmaceuticals Inc 29 Jan 2013 | | - Cons. EPS | - EPS |
VRTX Earnings Reports FAQ
What is the earnings per share (EPS) for VRTX?
The current EPS is 14.94.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 34.12%, reflecting the VRTX's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-04, based on the VRTX's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 4.8 per share, reported on 2025-11-10. For dividend history, visit the VRTX Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 90.53, calculated based on the most recent stock price of $434.52.
2025 © Marketlog. All Rights Reserved.
